Table 3.
Common obesity-related targets with the highest (>10) number of binding sites for miRNAs differentially expressed in subcutaneous (SAT) and visceral (VAT) adipose tissues of normal weight (N) and obese before (O) and after surgery (PO) individuals.
| SAT-O vs. SAT-N | SAT-O vs. SAT-PO | SAT-N vs. SAT-PO | VAT-O vs. SAT-O |
|---|---|---|---|
| PPARA | PRKAR1A | VEGFA | ADRB2 |
| CASP9 | CCND1 | CREB1 | VEGFA |
| PPARGC1B | PTEN | BCL2 | BCL2 |
| IGF1R | CDKN1A | FLT1 | SCARB1 |
| FMR1 | HMGA2 | MDM2 | CDC42 |
| SLC26A2 | HMGA1 | CCR2 | PAX8 |
| RAD51B | XIAP | PCDH15 | SP1 |
| MBD4 | CCND2 | EXOC7 | SLC16A1 |
| FOXP1 | SMAD4 | ARL17A | BICD1 |
| RNASEL | CADM1 | PARD3 | CSNK1D |
| CAMTA1 | SPRED1 | BICD1 | MCL1 |
| BMPR2 | MBD1 | ADRA1A | IL1RAP |
| VIPR2 | HSPA1B | TMPO | CLTC |
| DBT | NOTCH2 | QKI | CELF2 |
| CDS1 | BRWD1 | DNAJC10 | ENAH |
| WHSC1L1 | E2F3 | ZNF496 | HSPA13 |
| CELF1 | MAPK9 | PCDH7 | |
| DAPK2 | NRG1 | HDGF | |
| PHF20 | SLC2A3 | DYNC1I1 | |
| CRYL1 | KIF6 | PPP1R12B | |
| CCDC13 | HMBOX1 | ||
| TPGS2 |